Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir

Antiviral Therapy

Volumn 16, Issue 3, 2011, Pages 435-437

  De Kanter, Clara Tmm ^a   Keuter, Monique ^a   Van Der Lee, Manon J ^a   Koopmans, Peter P ^a   Burger, David M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATAZANAVIR PLUS RITONAVIR; BICARBONATE; CIPROFLOXACIN; CREATINE KINASE; CREATININE; LOPINAVIR PLUS RITONAVIR; PRAVASTATIN; RALTEGRAVIR; ROSUVASTATIN; TENOFOVIR;

ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG WITHDRAWAL; DYSLIPIDEMIA; DYSPNEA; FATIGUE; HEMATURIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; KIDNEY FAILURE; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETREATMENT; RHABDOMYOLYSIS; URINARY TRACT INFECTION;

ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; FLUOROBENZENES; HIV INFECTIONS; HIV-1; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PYRIMIDINES; PYRIMIDINONES; RENAL INSUFFICIENCY; RHABDOMYOLYSIS; RITONAVIR; SULFONAMIDES; TREATMENT OUTCOME;

EID: 79959397333     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1747     Document Type: Article

References (14)

1. Aberg JA. Cardiovascular complications in HIV management: past, present and future. J Acquir Immune Defic Syndr 2009; 50:54-64.
2. Burger D, Stroes E, Reiss P. Drug interactions between statins and antiretroviral agents. Curr Opin HIV AIDS 2008; 3:247-251. (Pubitemid 351521006)
3. Dubé MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis 2003; 37:613-627. (Pubitemid 37100800)
4. European AIDS Clinical Society. Guidelines: clinical management and treatment of HIV infected adults in Europe. Version 5, 2009. (Updated 27 July 2010. Accessed 14 September 2010.) Available from http://www. europeanaidsclinicalsociety.org/guidelines.asp
5. Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet 2002; 41:343-370. (Pubitemid 34713089)
6. Aarnoutse RE, Burger DM. When should we fear statin interactions? In Vissers MN (Editor). Evidence-based management of lipid disorders. 1st Ed. Castle Hill Barn, UK: Tfm Publishing Ltd 2010; pp. 267-283.
7. Viread (tenofovir disoproxil fumarate). Package insert 2007. Gilead Sciences Cambridge, UK.
8. van der Lee M, Sankatsing R, Schippers E, et al. Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients. Antivir Ther 2007; 12:1127-1132. (Pubitemid 350114993)
9. Kiser JJ, Gerber JG, Predhomme JA, Wolfe P, Flynn DM, Hoody DW. Drug/drug interaction between lopinavir/ ritonavir and rosuvastatin in healthy volunteers. J Acquir Immune Defic Syndr 2008; 47:570-578. (Pubitemid 351442013)
10. Crestor (rosuvastatin calcium). Package insert 2009. AstraZeneca Pharmaceuticals, Wilmington, DE, USA.
11. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245. (Pubitemid 12149145)
12. Cipro (ciprofloxacin hydrochloride). Package insert 2008. Schering Corporation, Kenilworth, NJ, USA.
13. Eisele S, Garbe E, Zeitz M, Schneider T, Somasundaram R. Ciprofloxacin-related acute severe myalgia necessitating emergency care treatment: a case report and review of the literature. Int J Clin Pharmacol Ther 2009; 47:165-168.
14. Sawant RD. Rhabdomyolysis due to an uncommon interaction of ciprofloxacin with simvastatin. Can J Clin Pharmacol 2009; 16:e78-e79.